Indira Gurubhagavatula of the Perelman School of Medicine says that ResMed Inc. has struggled to meet the spike in demand for sleep apnea treatments.
https://reut.rs/3cdYqJW ReutersIndira Gurubhagavatula of the Perelman School of Medicine says that ResMed Inc. has struggled to meet the spike in demand for sleep apnea treatments.
https://reut.rs/3cdYqJW Reuters